ArchVentures SA logo

ArchVentures SA

Europe, Faro, Portugal, Faro

Description

Decentralized holding company with interests in architecture and 3D printing.

Investor Profile

ArchVentures SA has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (67%)
  • Series C (17%)
  • Series E (17%)

Country Focus

  • United States (83%)
  • United Kingdom (17%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Commercial
  • Clinical Trials
  • Information Technology
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Battery
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ArchVentures SA frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Curie.Bio
North America, Massachusetts, United States, Boston
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
AV
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
Sands Capital Ventures
North America, Virginia, United States, Arlington
Co-Investments: 2

Which angels does ArchVentures SA often collaborate with?

MA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by ArchVentures SA?

Elephas

Madison, Wisconsin, United States

Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical
Series CJan 24, 2024
Amount Raised: $55,000,000
ROME Therapeutics

Cambridge, Massachusetts, United States

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

BiotechnologyHealth CarePharmaceutical
Series BSep 12, 2023
Amount Raised: $72,000,000
bit.bio

Cambridge, Cambridgeshire, United Kingdom

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

BiotechnologyCommercialHealth Care
Series BNov 5, 2021
Amount Raised: $103,000,000
Singular Genomics

La Jolla, California, United States

Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine.

BiotechnologyHealth CareMedical
Series BJan 1, 2020
Amount Raised: $45,500,000
908 Devices

Boston, Massachusetts, United States

908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.

BatteryChemicalHardwareManufacturing
Series EApr 29, 2019
Amount Raised: $17,500,000
Fast Track

San Mateo, California, United States

Fast Track is an information technology company focused on improving and expediting the clinical trials process.

Clinical TrialsHealth CareInformation Technology
Series BApr 5, 2000
Amount Raised: $15,600,000